Gallstone pancreatitis resident survival guide: Difference between revisions
Rim Halaby (talk | contribs) |
|||
(13 intermediate revisions by one other user not shown) | |||
Line 4: | Line 4: | ||
{{SK}} Biliary pancreatitis | {{SK}} Biliary pancreatitis | ||
== | ==Overview== | ||
Gallstone pancreatitis is an [[acute pancreatitis]] caused by [[gallstones]]. Gallstone pancreatitis is suspected when an acute pancreatitis patient with or without previous history of [[biliary colic]] or gallbladder related symptoms presents with elevated [[Alanine transaminase|serum alanine aminotransferase]] ([[ALT]]) levels and evidence of gallstones or common bile duct stones on abdominal ultrasound. | Gallstone pancreatitis is an [[acute pancreatitis]] caused by [[gallstones]]. Gallstone pancreatitis is suspected when an acute pancreatitis patient with or without previous history of [[biliary colic]] or gallbladder related symptoms presents with elevated [[Alanine transaminase|serum alanine aminotransferase]] ([[ALT]]) levels and evidence of gallstones or common bile duct stones on abdominal ultrasound. | ||
==Causes== | ==Causes== | ||
===Life Threatening Causes=== | ===Life Threatening Causes=== | ||
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Gallstone pancreatitis may be a life-threatening condition, especially if it presents with suppurative cholangitis and progresses to necrotizing pancreatitis, and should be treated as such irrespective of the causes. | Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Gallstone pancreatitis may be a life-threatening condition, especially if it presents with suppurative cholangitis and progresses to necrotizing pancreatitis, and it should be treated as such irrespective of the causes. | ||
===Common Causes=== | ===Common Causes=== | ||
*[[Cholelithiasis]] | *[[Cholelithiasis]] | ||
* [[Choledecholithiasis]] | |||
*[[Gallbladder sludge|Biliary sludge]]<ref name="Forsmark-2007">{{Cite journal | last1 = Forsmark | first1 = CE. | last2 = Baillie | first2 = J. | title = AGA Institute technical review on acute pancreatitis. | journal = Gastroenterology | volume = 132 | issue = 5 | pages = 2022-44 | month = May | year = 2007 | doi = 10.1053/j.gastro.2007.03.065 | PMID = 17484894 }}</ref> | *[[Gallbladder sludge|Biliary sludge]]<ref name="Forsmark-2007">{{Cite journal | last1 = Forsmark | first1 = CE. | last2 = Baillie | first2 = J. | title = AGA Institute technical review on acute pancreatitis. | journal = Gastroenterology | volume = 132 | issue = 5 | pages = 2022-44 | month = May | year = 2007 | doi = 10.1053/j.gastro.2007.03.065 | PMID = 17484894 }}</ref> | ||
Line 18: | Line 19: | ||
Shown below is an algorithm depicting the management of gallstone pancreatitis according to the American College of Gastroenterology (ACG)<ref name="Tenner-2013">{{Cite journal | last1 = Tenner | first1 = S. | last2 = Baillie | first2 = J. | last3 = DeWitt | first3 = J. | last4 = Vege | first4 = SS. | title = American College of Gastroenterology guideline: management of acute pancreatitis. | journal = Am J Gastroenterol | volume = 108 | issue = 9 | pages = 1400-15; 1416 | month = Sep | year = 2013 | doi = 10.1038/ajg.2013.218 | PMID = 23896955 }}</ref> and the Society for Surgery of the Alimentary Tract (SSAT).<ref name="Duncan-2012">{{Cite journal | last1 = Duncan | first1 = CB. | last2 = Riall | first2 = TS. | title = Evidence-based current surgical practice: calculous gallbladder disease. | journal = J Gastrointest Surg | volume = 16 | issue = 11 | pages = 2011-25 | month = Nov | year = 2012 | doi = 10.1007/s11605-012-2024-1 | PMID = 22986769 }}</ref> | Shown below is an algorithm depicting the management of gallstone pancreatitis according to the American College of Gastroenterology (ACG)<ref name="Tenner-2013">{{Cite journal | last1 = Tenner | first1 = S. | last2 = Baillie | first2 = J. | last3 = DeWitt | first3 = J. | last4 = Vege | first4 = SS. | title = American College of Gastroenterology guideline: management of acute pancreatitis. | journal = Am J Gastroenterol | volume = 108 | issue = 9 | pages = 1400-15; 1416 | month = Sep | year = 2013 | doi = 10.1038/ajg.2013.218 | PMID = 23896955 }}</ref> and the Society for Surgery of the Alimentary Tract (SSAT).<ref name="Duncan-2012">{{Cite journal | last1 = Duncan | first1 = CB. | last2 = Riall | first2 = TS. | title = Evidence-based current surgical practice: calculous gallbladder disease. | journal = J Gastrointest Surg | volume = 16 | issue = 11 | pages = 2011-25 | month = Nov | year = 2012 | doi = 10.1007/s11605-012-2024-1 | PMID = 22986769 }}</ref> | ||
{{familytree/start|summary=Gallstone pancreatitis}} | {{familytree/start|summary=Gallstone pancreatitis}} | ||
{{familytree | {{familytree | | | | | | | | A01 | | | | | | | | | | | | | | |A01=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''Characterize the symptoms:''' <br> ❑ Severe [[abdominal pain]] and/or <br> ❑ [[Dyspnea|Breathing difficulty]] and/or <br> ❑ [[Nausea]] & [[vomiting]] and/or <br> ❑ [[Hiccups]] sometimes </div> }} | ||
{{familytree | {{familytree | | | | | | | | |!| | | | | | | | | | | | | | | |}} | ||
{{familytree | {{familytree | | | | | | | | A11 | | | | | | | | | | | | | | |A11=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''Examine the patient:''' <br> ❑ [[Fever]] and/or <br> ❑ [[Hypotension]] and/or <br> ❑ [[Cullen's sign]] and/or <br> ❑ [[Grey-Turner's sign]] and/or <br> ❑ [[Tachypnea]] and/or <br> ❑ [[Abdominal distension]] and/or [[tenderness]]</div>}} | ||
{{familytree | {{familytree | | | | | | | | |!| | | | | | | | | | | | | | | |}} | ||
{{familytree | {{familytree | | | | | | | | A12 | | | | | | | | | | | | | | |A12=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''Consider alternative diagnosis:''' <br> ❑ [[Gallstones]] <br> ❑ [[Dissecting aortic aneurysm]] <br> ❑ [[Pancreatic pseudocyst]] </div> }} | ||
{{familytree | {{familytree | | | | | | | | |!| | | | | | | | | | | | | | | |}} | ||
{{familytree | {{familytree | | | | | | | | E01 |-|-|-|-|-|-|.| | |E01=Hemodynamic stability? }} | ||
{{familytree | {{familytree | | | | | | | | |!| | | | | | | |!| |}} | ||
{{familytree |border=0 | {{familytree |border=0 | | | | | | | | Z01 | | | | | | Z02 | | | | |Z01 = Stable|Z02= Unstable }} | ||
{{familytree | {{familytree | | | | | | | | |!| | | | | | | |!| |}} | ||
{{familytree | {{familytree | | | | | | | | B01 | | | | | | B03 | | ||
B01=<div style="float: left; text-align: left; | B01=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''Order Labs: (Urgent)''' <br> ❑ [[CBC]] <br> ❑ [[Hematocrit]] <br> ❑ [[BUN]] <br> ❑ [[Creatinine]] <br> ❑ [[Amylase]] <br> ❑ [[Lipase]] <br> ❑ [[Triglyceride]] <br>❑ Total [[bilirubin]]<br>❑ Direct [[bilirubin]]<br>❑ [[Albumin]]<br>❑ [[AST]]<br>❑ [[ALT]]<br>❑ [[Alkaline phosphatase]]<br>❑ [[GGT]]<br> ❑ [[Chest X-ray]] | ||
---- | ---- | ||
'''Order imaging studies: (Urgent)''' <br> Trans abdominal USG (TAUSG) </div>|B03=Stabilize the patient}} | '''Order imaging studies: (Urgent)''' <br> Trans abdominal USG (TAUSG) </div>|B03=Stabilize the patient}} | ||
{{familytree | {{familytree | | | | | | | | |!| | | | | | | | | | | | | | | |}} | ||
{{familytree | {{familytree | | | | | | | | C01 | | | | | | | | | | | | | | |C01=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''Diagnostic criteria: Any 2 out of 3''' <br> ❑ Abdominal pain consistent with disease<br> ❑ Serum amylase or lipase values > 3 times normal <br> ❑ Consistent findings from abdominal imaging </div>}} | ||
{{familytree | {{familytree | | | | | | | | |!| | | | | | | | | | | | | | | |}} | ||
{{familytree | {{familytree | | | | | | | | D01 | | | | | | | | | | | | | | |D01='''Acute Pancreatitis'''}} | ||
{{familytree | {{familytree | | | | | | | | |!| | | | | | | | | | | | | | | |}} | ||
{{familytree | {{familytree | | | | | | | | F01 |-|-|-|-|-| F02 |-|.| | | | |F01=[[Systemic inflammatory response syndrome]]? '''(Urgent)''' |F02=Yes|"border=0" }} | ||
{{familytree | {{familytree | | | | | | | | |!| | | | | | | | | | |!| | | | |}} | ||
{{familytree |border=0 | {{familytree |border=0 | | | | | | | | AA1 | | | | | | | | | |!| | | | |AA1=No}} | ||
{{familytree | {{familytree | | | | | | | | |!| | | | | | | | | | |!| | | | |}} | ||
{{familytree | {{familytree | | | | | | | | G01 | | | | | | | | | |!| | | | |G01=Risk stratification for organ failure<br> ([[Gallstone pancreatitis resident survival guide#Modified Marshall Scoring System|Marshall scoring]]) '''(Urgent)'''}} | ||
{{familytree | {{familytree | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| | | |!| | | | |}} | ||
{{familytree | {{familytree | H01 | | | | | | | | | | | | H02 | | |!| | | | |H01=Lower risk |H02=Higher risk}} | ||
{{familytree | {{familytree | |!| | | | | | | | | | | | | |!| | | |!| | | | |}} | ||
{{familytree | {{familytree | I01 | | | | | | | | | | | | I02 |-|-|'| | | | |I01= Admit to medical ward |I02=Admit to ICU '''(Urgent)'''}} | ||
{{familytree | {{familytree | |!| | | | | | | | | | | | | |!| | | | | | | | |}} | ||
{{familytree | {{familytree | J01 | | | | | | | | | | | | J02 | | | | | | | |J01=<div style="float: left; text-align: left; width: 20em; padding:1em;"> '''Fluids: (Urgent)''' <br><br> ❑ Aggressive hydration at 250-500 ml/hr with Ringer's lactate in first 12-24 hours<br> ❑ Reassess within 6 hours after admission and for next 24-48 hours | ||
---- | ---- | ||
'''Analgesics: (Urgent)''' <br><br> ❑ Opioids are preferred <br> ❑ Mepridine & morphine may be used as IV drips/pt. controlled analgesia | '''Analgesics: (Urgent)''' <br><br> ❑ Opioids are preferred <br> ❑ Mepridine & morphine may be used as IV drips/pt. controlled analgesia | ||
---- | ---- | ||
'''Nutrition: (Urgent)''' <br><br> ❑ Immediate oral feeding as soon as pain, vomiting, nausea subside </div> | '''Nutrition: (Urgent)''' <br><br> ❑ Immediate oral feeding as soon as pain, vomiting, nausea subside </div> | ||
|J02=<div style="float: left; text-align: left; | |J02=<div style="float: left; text-align: left; width: 20em; padding:1em;">'''Fluids: (Urgent)''' <br> ❑ Initiate with a fluid bolus <br> ❑ Aggressive hydration at 250-500 ml/hr with Ringer's lactate in first 12-24 hours <br> ❑ Reassess within 6 hours after admission and for next 24-48 hours | ||
---- | ---- | ||
'''Analgesics: (Urgent)''' <br> ❑ Opioids are preferred <br> ❑ Mepridine & morphine may be used as IV drips/pt. controlled analgesia | '''Analgesics: (Urgent)''' <br> ❑ Opioids are preferred <br> ❑ Mepridine & morphine may be used as IV drips/pt. controlled analgesia | ||
---- | ---- | ||
'''Nutrition: (Urgent)''' <br> ❑ Nasogastric or nasojejunal feeding may be initiated once pain, vomiting, nausea subside <br> ❑ Consider enteral feeding if above not tolerated </div>}} | '''Nutrition: (Urgent)''' <br> ❑ Nasogastric or nasojejunal feeding may be initiated once pain, vomiting, nausea subside <br> ❑ Consider enteral feeding if above not tolerated </div>}} | ||
{{familytree | {{familytree | |`|-|-|-|-|-|-|v|-|-|-|-|-|-|'| | | | | | | | |}} | ||
{{familytree | {{familytree | | | | | | | | K01 | | | | | | | | | | | | |K01=<div style="float: left; text-align: left; width: 20em; padding:1em;">❑ ± Previous history of biliary colic or GB related Sx<br> ❑ Elevated ALT<br> ❑ ± Elevated AST<br> ❑ Gallstones detected during TAUSG</div>}} | ||
{{familytree | {{familytree | | | | | | | | |!| | | | | | | | | | | | | | | |}} | ||
{{familytree | {{familytree | | | | | | | | L01 | | | | | | | | | | | | | | | |L01='''Gallstone pancreatitis'''}} | ||
{{familytree | {{familytree | | | |,|-|-|-|-|^|-|-|-|-|.| | | | | | | | | | | | | | | | }} | ||
{{familytree | {{familytree | | | M01 | | | | | | | | M02 | | | | | | | | | | | | | | | |M01='''Mild'''|M02='''Severe'''}} | ||
{{familytree | {{familytree | |,|-|^|-|.| | | | | | | |!| | | | | | | | | | | |}} | ||
{{familytree | {{familytree | N01 | | N02 | | | | | | N03 | | | | | | | | | | | | | |N01=Good surgical candidates|N02=Bad surgical candidates|N03=<div style="float: left; text-align: left; width: 20em; padding:1em;">❑ Continue resuscitative & supportive care<br>❑ Early ERCP within 24 hours</div> }} | ||
{{familytree | {{familytree | |!| | | |!| | | | |,|-|-|^|-|-|.| | | | | | | | |}} | ||
{{familytree | {{familytree | O01 | | O02 | | | O03 | | | | O04 | | | | | | | | | | | | | | | | | |O01=<div style="float: left; text-align: left; padding:1em;">❑ Laparoscopic cholecystectomy during index hospitalization<ref name="Uhl-2002">{{Cite journal | last1 = Uhl | first1 = W. | last2 = Warshaw | first2 = A. | last3 = Imrie | first3 = C. | last4 = Bassi | first4 = C. | last5 = McKay | first5 = CJ. | last6 = Lankisch | first6 = PG. | last7 = Carter | first7 = R. | last8 = Di Magno | first8 = E. | last9 = Banks | first9 = PA. | title = IAP Guidelines for the Surgical Management of Acute Pancreatitis. | journal = Pancreatology | volume = 2 | issue = 6 | pages = 565-73 | month = | year = 2002 | doi = 71269 | PMID = 12435871 }}</ref><br>❑ IOC<br>❑ ± Intra/postoperative ERCP</div>|O02=❑ ERCP with endoscopic sphincterotomy|O03= Presence of infection|O04=Absence of infection }} | ||
{{familytree | {{familytree | | | | | | | | | | |!| | | |,|-|^|-|.| | | | | | | |}} | ||
{{familytree | {{familytree | | | | | | | | | | P01 | | P02 | | P03 | | | | | | | |P01=❑ Surgical intervention|P02=Good surgical candidates|P03=Bad surgical candidates}} | ||
{{familytree | {{familytree | | | | | | | | | | | | | | |!| | | |!| | | | | | | |}} | ||
{{familytree | {{familytree | | | | | | | | | | | | | | Q01 | | Q02 | | | | | | | | |Q01=❑ Delayed cholecystectomy|Q02=❑ ERCP with endoscopic sphincterotomy}} | ||
{{familytree/end}} | {{familytree/end}} | ||
< | <span style="font-size:85%">'''ALT:''' Alanine aminotransferase; '''AST:''' Aspartate aminotransferase; '''BUN:''' Blood urea nitrogen; '''CBC:''' Complete blood count; '''ERCP:''' Endoscopic retrograde cholangiopancreatography; '''GB:''' Gallbladder; '''GGT:''' Gamma-glutamyl transpeptidase; '''H/o''' History of; '''ICU''': Intensive care unit; '''IOC:''' Intraoperative cholangiography; '''IV:''' Intravenous; '''Sx:''' Symptom </span> | ||
==Modified Marshall Scoring System== | |||
{| {{table}} | |||
|+ '''Modified Marshall Scoring System<sup>†</sup>''' | |||
| align="left" width=200px style="background:#f0f0f0;"|'''Organ System''' | |||
| align="left" width=150px style="background:#f0f0f0;"|'''0''' | |||
| align="left" width=150px style="background:#f0f0f0;"|'''1''' | |||
| align="left" width=150px style="background:#f0f0f0;"|'''2''' | |||
| align="left" width=150px style="background:#f0f0f0;"|'''3''' | |||
| align="left" width=150px style="background:#f0f0f0;"|'''4''' | |||
|- | |||
| valign="bottom" width=200px | '''Respiratory''' <BR> PaO2/FiO2 | |||
| valign="bottom" width=150px | >400 | |||
| valign="bottom" width=150px | 301-400 | |||
| valign="bottom" width=150px | 201-300 | |||
| valign="bottom" width=150px | 101-200 | |||
| valign="bottom" width=150px | ≤101 | |||
|- | |||
| valign="bottom" width=200px | '''Renal<sup>‡</sup>''' <BR> Creatinine (μmol/l) <BR> Creatinine (mg/dl) | |||
| valign="bottom" width=150px | ≤134 <BR> <1.4 | |||
| valign="bottom" width=150px | 134-169 <BR> 1.4-1.8 | |||
| valign="bottom" width=150px | 170-310 <BR> 1.9-3.6 | |||
| valign="bottom" width=150px | 311-439 <BR> 3.6-4.9 | |||
| valign="bottom" width=150px | >439 <BR> >4.9 | |||
|- | |||
| valign="bottom" width=200px | '''Cardiovascular''' <BR> Systolic Blood Pressure (mmHg) | |||
| valign="bottom" width=150px | >90 | |||
| valign="bottom" width=150px | <90, fluid responsive | |||
| valign="bottom" width=150px | <90, not fluid responsive | |||
| valign="bottom" width=150px | <90, pH <7.3 | |||
| valign="bottom" width=150px | <90, pH <7.2 | |||
|- | |||
|} | |||
<sup>†</sup> A score of 2 or more in any system defines the presence of organ failure. <BR> | |||
<sup>‡</sup> A score for patients with pre-existing chronic renal failure depends on the extent of further deterioration of baseline renal function. No formal correction exists for a baseline creatinine ≥134 μmol/l or ≥1.4 mg/dl. | |||
▸ ''For non-ventilated patients, the FiO2 can be estimated from below:'' | |||
{| {{table}} | |||
| align="center" style="background:#f0f0f0;"|'''Supplemental oxygen (l/min)''' | |||
| align="center" style="background:#f0f0f0;"|'''FiO2 (%)''' | |||
|- | |||
| Room air||21 | |||
|- | |||
| 2||25 | |||
|- | |||
| 4||30 | |||
|- | |||
| 6–8 ||40 | |||
|- | |||
| 9–10||50 | |||
|} | |||
==Grades of Severity== | ==Grades of Severity== | ||
Line 97: | Line 149: | ||
==Dont's== | ==Dont's== | ||
*Do not | *Do not request an [[ERCP]] in patients with gallstone pancreatitis who lack laboratory or clinical evidence of ongoing biliary obstruction ([[GRADE system classification scheme|strong recommendation, low quality of evidence]]). | ||
==References== | ==References== |
Latest revision as of 14:49, 12 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vendhan Ramanujam M.B.B.S [2]
Synonyms and keywords: Biliary pancreatitis
Overview
Gallstone pancreatitis is an acute pancreatitis caused by gallstones. Gallstone pancreatitis is suspected when an acute pancreatitis patient with or without previous history of biliary colic or gallbladder related symptoms presents with elevated serum alanine aminotransferase (ALT) levels and evidence of gallstones or common bile duct stones on abdominal ultrasound.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Gallstone pancreatitis may be a life-threatening condition, especially if it presents with suppurative cholangitis and progresses to necrotizing pancreatitis, and it should be treated as such irrespective of the causes.
Common Causes
Management
Shown below is an algorithm depicting the management of gallstone pancreatitis according to the American College of Gastroenterology (ACG)[2] and the Society for Surgery of the Alimentary Tract (SSAT).[3]
Characterize the symptoms: ❑ Severe abdominal pain and/or ❑ Breathing difficulty and/or ❑ Nausea & vomiting and/or ❑ Hiccups sometimes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Examine the patient: ❑ Fever and/or ❑ Hypotension and/or ❑ Cullen's sign and/or ❑ Grey-Turner's sign and/or ❑ Tachypnea and/or ❑ Abdominal distension and/or tenderness | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hemodynamic stability? | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stable | Unstable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Order Labs: (Urgent) ❑ CBC ❑ Hematocrit ❑ BUN ❑ Creatinine ❑ Amylase ❑ Lipase ❑ Triglyceride ❑ Total bilirubin ❑ Direct bilirubin ❑ Albumin ❑ AST ❑ ALT ❑ Alkaline phosphatase ❑ GGT ❑ Chest X-ray Order imaging studies: (Urgent) Trans abdominal USG (TAUSG) | Stabilize the patient | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnostic criteria: Any 2 out of 3 ❑ Abdominal pain consistent with disease ❑ Serum amylase or lipase values > 3 times normal ❑ Consistent findings from abdominal imaging | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acute Pancreatitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Systemic inflammatory response syndrome? (Urgent) | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Risk stratification for organ failure (Marshall scoring) (Urgent) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lower risk | Higher risk | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Admit to medical ward | Admit to ICU (Urgent) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fluids: (Urgent) ❑ Aggressive hydration at 250-500 ml/hr with Ringer's lactate in first 12-24 hours ❑ Reassess within 6 hours after admission and for next 24-48 hours Analgesics: (Urgent) Nutrition: (Urgent) ❑ Immediate oral feeding as soon as pain, vomiting, nausea subside | Fluids: (Urgent) ❑ Initiate with a fluid bolus ❑ Aggressive hydration at 250-500 ml/hr with Ringer's lactate in first 12-24 hours ❑ Reassess within 6 hours after admission and for next 24-48 hours Analgesics: (Urgent) Nutrition: (Urgent) ❑ Nasogastric or nasojejunal feeding may be initiated once pain, vomiting, nausea subside ❑ Consider enteral feeding if above not tolerated | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ ± Previous history of biliary colic or GB related Sx ❑ Elevated ALT ❑ ± Elevated AST ❑ Gallstones detected during TAUSG | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gallstone pancreatitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mild | Severe | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Good surgical candidates | Bad surgical candidates | ❑ Continue resuscitative & supportive care ❑ Early ERCP within 24 hours | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ ERCP with endoscopic sphincterotomy | Presence of infection | Absence of infection | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Surgical intervention | Good surgical candidates | Bad surgical candidates | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Delayed cholecystectomy | ❑ ERCP with endoscopic sphincterotomy | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BUN: Blood urea nitrogen; CBC: Complete blood count; ERCP: Endoscopic retrograde cholangiopancreatography; GB: Gallbladder; GGT: Gamma-glutamyl transpeptidase; H/o History of; ICU: Intensive care unit; IOC: Intraoperative cholangiography; IV: Intravenous; Sx: Symptom
Modified Marshall Scoring System
Organ System | 0 | 1 | 2 | 3 | 4 |
Respiratory PaO2/FiO2 |
>400 | 301-400 | 201-300 | 101-200 | ≤101 |
Renal‡ Creatinine (μmol/l) Creatinine (mg/dl) |
≤134 <1.4 |
134-169 1.4-1.8 |
170-310 1.9-3.6 |
311-439 3.6-4.9 |
>439 >4.9 |
Cardiovascular Systolic Blood Pressure (mmHg) |
>90 | <90, fluid responsive | <90, not fluid responsive | <90, pH <7.3 | <90, pH <7.2 |
† A score of 2 or more in any system defines the presence of organ failure.
‡ A score for patients with pre-existing chronic renal failure depends on the extent of further deterioration of baseline renal function. No formal correction exists for a baseline creatinine ≥134 μmol/l or ≥1.4 mg/dl.
▸ For non-ventilated patients, the FiO2 can be estimated from below:
Supplemental oxygen (l/min) | FiO2 (%) |
Room air | 21 |
2 | 25 |
4 | 30 |
6–8 | 40 |
9–10 | 50 |
Grades of Severity
The definitions of severity in acute pancreatitis according to the revised Atlanta classification is as follows.[5]
- Mild acute pancreatitis
- ▸ No organ failure
- ▸ No local or systemic complications
- Moderately severe acute pancreatitis
- ▸ Organ failure that resolves within 48 h (transient organ failure) and/or
- ▸ Local or systemic complications without persistent organ failure
- Severe acute pancreatitis
- ▸ Persistent organ failure (>48 h)
- – Single organ failure
- – Multiple organ failure
Do's
- Refer the patient for prompt cholecystectomy once gallstones are identified as the etiology for pancreatitis in order to prevent recurrent attacks and potential biliary sepsis.[6]
- Perform cholecystectomy before discharging the patient with mild acute pancreatitis due to gallstones in order to prevent the recurrence (strong recommendation, moderate quality of evidence).
- Perform cholecystectomy in mild acute pancreatitis after resolution of abdominal pain and normalization of laboratory values.[7]
- Consider serum triglyceride as the etiology if its >1000 mg/dl in the absence of gallstones and/or history of significant history of alcohol use (conditional recommendation, moderate quality of evidence).
Dont's
- Do not request an ERCP in patients with gallstone pancreatitis who lack laboratory or clinical evidence of ongoing biliary obstruction (strong recommendation, low quality of evidence).
References
- ↑ Forsmark, CE.; Baillie, J. (2007). "AGA Institute technical review on acute pancreatitis". Gastroenterology. 132 (5): 2022–44. doi:10.1053/j.gastro.2007.03.065. PMID 17484894. Unknown parameter
|month=
ignored (help) - ↑ Tenner, S.; Baillie, J.; DeWitt, J.; Vege, SS. (2013). "American College of Gastroenterology guideline: management of acute pancreatitis". Am J Gastroenterol. 108 (9): 1400–15, 1416. doi:10.1038/ajg.2013.218. PMID 23896955. Unknown parameter
|month=
ignored (help) - ↑ Duncan, CB.; Riall, TS. (2012). "Evidence-based current surgical practice: calculous gallbladder disease". J Gastrointest Surg. 16 (11): 2011–25. doi:10.1007/s11605-012-2024-1. PMID 22986769. Unknown parameter
|month=
ignored (help) - ↑ Uhl, W.; Warshaw, A.; Imrie, C.; Bassi, C.; McKay, CJ.; Lankisch, PG.; Carter, R.; Di Magno, E.; Banks, PA. (2002). "IAP Guidelines for the Surgical Management of Acute Pancreatitis". Pancreatology. 2 (6): 565–73. doi:71269 Check
|doi=
value (help). PMID 12435871. - ↑ Banks, PA.; Bollen, TL.; Dervenis, C.; Gooszen, HG.; Johnson, CD.; Sarr, MG.; Tsiotos, GG.; Vege, SS.; Acosta, JM. (2013). "Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus". Gut. 62 (1): 102–11. doi:10.1136/gutjnl-2012-302779. PMID 23100216. Unknown parameter
|month=
ignored (help) - ↑ Yadav, D.; O'Connell, M.; Papachristou, GI. (2012). "Natural history following the first attack of acute pancreatitis". Am J Gastroenterol. 107 (7): 1096–103. doi:10.1038/ajg.2012.126. PMID 22613906. Unknown parameter
|month=
ignored (help) - ↑ Gurusamy, KS.; Davidson, BR. (2010). "Surgical treatment of gallstones". Gastroenterol Clin North Am. 39 (2): 229–44, viii. doi:10.1016/j.gtc.2010.02.004. PMID 20478484. Unknown parameter
|month=
ignored (help)